{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Pathak S"],"funding":["British Heart Foundation","Biomedical Research Centre","National Institute for Health Research (NIHR)"],"pagination":["351-364"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9890210"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["44(5)"],"pubmed_abstract":["Aims
The choice of revascularization with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in people with ischaemic left ventricular dysfunction is not guided by high-quality evidence.Methods and results
A trial of CABG vs. PCI in people with heart failure (HF) was modelled in silico using routinely collected healthcare data. The in silico trial cohort was selected by matching the target trial cohort, identified from Hospital Episode Statistics in England, with individual patient data from the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Allocation to CABG vs. complex PCI demonstrated random variation across administrative regions in England and was a valid statistical instrument. The primary outcome was 5-year all-cause mo"],"journal":["European heart journal"],"pubmed_title":["Surgical or percutaneous coronary revascularization for heart failure: an in silico model using routinely collected health data to emulate a clinical trial."],"pmcid":["PMC9890210"],"funding_grant_id":["CH/12/1/29419","10/57/67","RG/13/6/29947","CH/12/1/29419, AA18/3/34220","CL-2020-11-003"],"pubmed_authors":["Pathak S","Dearling J","Murray S","Lai FY","Miksza J","Murphy GJ","Perera D","Roman M","Petrie MC"],"additional_accession":[]},"is_claimable":false,"name":"Surgical or percutaneous coronary revascularization for heart failure: an in silico model using routinely collected health data to emulate a clinical trial.","description":"Aims
The choice of revascularization with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in people with ischaemic left ventricular dysfunction is not guided by high-quality evidence.Methods and results
A trial of CABG vs. PCI in people with heart failure (HF) was modelled in silico using routinely collected healthcare data. The in silico trial cohort was selected by matching the target trial cohort, identified from Hospital Episode Statistics in England, with individual patient data from the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Allocation to CABG vs. complex PCI demonstrated random variation across administrative regions in England and was a valid statistical instrument. The primary outcome was 5-year all-cause mo","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2026-05-28T20:47:33.803Z","creation":"2024-12-03T18:07:48.137Z"},"accession":"S-EPMC9890210","cross_references":{"pubmed":["36350978"],"doi":["10.1093/eurheartj/ehac670"]}}